4//SEC Filing
Drutz David 4
Accession 0001104659-23-105401
CIK 0001326190other
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 5:01 PM ET
Size
5.7 KB
Accession
0001104659-23-105401
Insider Transaction Report
Form 4
Drutz David
Director
Transactions
- Award
Stock Options (option to buy)
2023-09-28+26,100→ 26,100 totalExercise: $2.50Exp: 2033-09-28→ Common Stock, par value $0.0001 (26,100 underlying)
Footnotes (1)
- [F1]The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001428764
Filing Metadata
- Form type
- 4
- Filed
- Sep 28, 8:00 PM ET
- Accepted
- Sep 29, 5:01 PM ET
- Size
- 5.7 KB